4Rikel A, Boucher A, Ste-Marie LG. Role of zoledronic acid in the prevention and treatment of osteoporosis[J]. Clin Interv Aging, 2011 (6): 89-99.
5Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis[J]. N Engl J Med, 2007, 356(18): 1809-1822.
6Lyles KW, Col6n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture [J]. N Engl J Med, 2007, 357(18) : 1799-1809.
7Reid IR,Brown JP,Burckhardt P,et al.Intravenous zoledronic acid in postmenopausal women with low bone mineral density[J].N Engl J Med,200,346(9):653-661.
8Lyles KW,Colón-Emeric CS,Magaziner JS,et al.Zoledronic acid and clinical fractures and mortality after hip fracture[J].Engl J Med,2007,357:1799-1809.
9DM Black,PD Delmas,R Eastell.Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis[J].The New England Journal of Medicine,2007.
10Cramer JA,Amonkar MM,Hebborn A,et al.Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis[J].Current Medical Research and Opinion,2005.
